Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Greater Cannabis CoGCAN 30 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates GCAN with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 960 Drug Manufacturers companies, Greater Cannabis Co ranks worse than 104166.56% on this metric.
The historical rank and industry rank for Greater Cannabis Co's FCF Margin % or its related term are showing as below:
During the past 10 years, the highest FCF Margin % of Greater Cannabis Co was -105.26%. The lowest was -4071.43%. And the median was -1231.97%.
GCAN's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.39 * Ranked among companies with meaningful FCF Margin % only.
The historical data trend for Greater Cannabis Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Greater Cannabis Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Greater Cannabis Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Greater Cannabis Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Greater Cannabis Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Greater Cannabis Co (GCAN) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Greater Cannabis Co and its competitors. According to the industry distribution chart, Greater Cannabis Co ranks #999999 out of 960 companies in the Drug Manufacturers industry.
Is Greater Cannabis Co's FCF Margin % too high?
Greater Cannabis Co's current FCF Margin % is 0.00%. Based on the distribution chart, Greater Cannabis Co ranks #999999 out of 960 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Greater Cannabis Co has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Greater Cannabis Co's FCF Margin % compare to STEK and KAYS?
According to the Drug Manufacturers industry distribution chart, Greater Cannabis Co ranks #999999 out of 960 companies for FCF Margin %. This places Greater Cannabis Co in the lower half of its industry. The industry median FCF Margin % is 2.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.39, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Greater Cannabis Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Greater Cannabis Co's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greater Cannabis Co stock overvalued right now?
Greater Cannabis Co (GCAN) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Greater Cannabis Co's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Greater Cannabis Co (GCAN), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Greater Cannabis Co Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a pharma-grade therapeutic that reduces disruptive symptoms in patients suffering from neuropsychiatric disorders without the side effects of existing medications. The company is focused on developing new formulations around cannabinoid therapeutics.
30GF Score
Get the complete analysis for GCAN
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GCAN has been successfully added to your 
